Welcome to the BADBIR database

You have been automatically logged out. If you were still working on a database page prior to log out there is a possibility this data was not saved. Please log in again.

Welcome to the BADBIR Database

1/5 Read more: Changes to conventional cohort eligibility criteria
2/5 Recruitment to Taltz has restarted
3/5 Our BADBIR Annual Update for 2024 is now available on the website here for everyone to read
4/5 Patients diagnosed with Generalised Pustular Psoriasis are eligible on Spevigo (spesolimab) or conventional treatment
5/5 Reminder that we currently recruit for patients on Sotyktu (deucravacitinib)